Nephrogen Information

Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

Website	http://nephrogenbiotech.com
Revenue	$5 million
Employees	3 (3 on RocketReach)
Founded	2022
Phone	+1 978-799-8358
Technologies	JavaScript , HTML , Twitter +8 more (view full list)
Industry	Biotechnology Research, Business Services General, Biotechnology, Diagnostic Equipment, Business Services, Science and Engineering, Other Healthcare Technology Systems, Health Diagnostics, Health Care, Medical, Therapeutics
Keywords	Gene Therapy, Kidney Disease, Rare Disease Treatment, Renal Disease Treatment, Biotechnology, Drug Development, Clinical Trials, Pharmaceutical Research, Genetic Therapies, Cell Therapy, Regenerative Medicine, Precision Medicine, Novel Therapies, Targeted Therapies, Kidney Research
Competitors	Reata Pharmaceuticals, Inc., Kadmon, a Sanofi Company, MediWound Ltd., CVRx \| Barostim, NantKwest, Amgen, Lilly India, Fresenius Medical Care, Novartis, Pfizer +36 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies